BDMD
OtherBaird Medical Investment Holdings Ltd .
Live · NASDAQ · May 9, Close
What's Moving BDMD Today?
No stock-specific AI insight has been generated for BDMD yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Trading
BDMD News
20 articles- Baird Medical Reports Full Year 2025 Financial Results and Provides Corporate UpdateYahoo Finance·Apr 29, 2026
- Baird Medical Advances Clinical Education with Expert-Led Workshops in IndonesiaYahoo Finance·Mar 16, 2026
- Baird Medical Expands Global Reach with Regulatory Clearance in ArgentinaYahoo Finance·Mar 12, 2026
- Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026Yahoo Finance·Mar 9, 2026
- Baird Medical Accelerates Global Registration of AI-Driven Surgical SoftwareYahoo Finance·Mar 4, 2026
- Baird Medical Accelerates U.S. Expansion at NASOIE 2026Yahoo Finance·Mar 2, 2026
- Baird Medical Accelerates U.S. Expansion in Interventional ThyroidologyYahoo Finance·Feb 25, 2026
- Baird Medical to Showcase Minimally Invasive Thyroid Solutions at Upcoming US Clinical ConferencesYahoo Finance·Feb 19, 2026
- Baird Medical Drives U.S. Market Penetration with Commercial Launch at Bakersfield Memorial HospitalYahoo Finance·Feb 11, 2026
- Baird Medical Accelerates Global Commercial Roadmap with Strategic Clinical Education Initiatives in the U.S. and JapanYahoo Finance·Feb 9, 2026
- Baird Medical Successfully Concludes Gynecology Microwave Ablation MasterclassYahoo Finance·Jan 28, 2026
- Baird Medical Accelerates Global Commercial Roadmap through Strategic Partnership with Stonewood Key CapitalYahoo Finance·Jan 26, 2026
- Baird Medical Highlights Strategic Engagement at 2026 J.P. Morgan Healthcare ConferenceYahoo Finance·Jan 20, 2026
- Baird Medical Secures Regulatory Approvals in Pakistan and VietnamYahoo Finance·Jan 7, 2026
- Baird Medical Establishes U.S. Manufacturing Base to Accelerate Global Expansion and Future R&DYahoo Finance·Dec 17, 2025
- Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial ExpansionYahoo Finance·Dec 3, 2025
- Baird Medical Enters Egyptian Market with First Successful Bone Tumor AblationYahoo Finance·Nov 3, 2025
- Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York PracticeYahoo Finance·Oct 27, 2025
- Baird Medical Announces First Successful Liver Tumor Ablation in BangladeshYahoo Finance·Oct 23, 2025
- /C O R R E C T I O N -- BDMD/Yahoo Finance·Oct 21, 2025
All 20 articles loaded
Price Data
Fundamentals
Trading
About Baird Medical Investment Holdings Ltd .
Baird Medical Investment Holdings Ltd is one of the microwave ablation medical device developers and providers in the PRC for minimally invasive treatment of tumors. Its proprietary medical devices are used for the treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer, and breast lumps. Microwave ablation is a minimally invasive treatment technique that denaturalizes and coagulates the protein of tumor cells with extreme heat generated by microwave energy. Microwave ablation treatments have been applied to benign and malignant tumors, and the company believes the products are safer, minimally invasive and easier to operate with faster recovery periods and lower complication rates for patients, as compared to traditional treatment methods.